CARDIOMYOPATHY
Clinical trials for CARDIOMYOPATHY explained in plain language.
Never miss a new study
Get alerted when new CARDIOMYOPATHY trials appear
Sign up with your email to follow new studies for CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gene therapy trial for rare heart condition halted before it began
Disease control TerminatedThis study was designed to test a new gene therapy called ASP2016 for heart problems caused by Friedreich Ataxia, a rare genetic disease. The therapy aimed to deliver a healthy copy of the faulty gene to help the heart. However, the study was withdrawn before any participants wer…
Matched conditions: CARDIOMYOPATHY
Phase: PHASE1 • Sponsor: Astellas Gene Therapies • Aim: Disease control
Last updated Jun 18, 2026 11:53 UTC
-
Weight-Loss drug semaglutide tested as heart failure treatment
Symptom relief ENROLLING_BY_INVITATIONThis study looks at whether aggressive weight loss using semaglutide can improve symptoms in people with a specific type of heart failure linked to obesity. About 81 participants with a BMI of 30 or higher and heart failure with preserved ejection fraction will receive either sem…
Matched conditions: CARDIOMYOPATHY
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 17, 2026 12:07 UTC
-
Global heart registry tracks ablation success
Knowledge-focused ENROLLING_BY_INVITATIONThis study is a large international registry that collects information from patients who have a heart ablation procedure for ventricular tachycardia or premature ventricular contractions. The goal is to track how well the procedure works and any complications, helping doctors imp…
Matched conditions: CARDIOMYOPATHY
Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:04 UTC